Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Analysis


  • Type: Oncology area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 176

  • Format: PPT, PDF

Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Segmented By Therapy (Targeted Therapy, Immunotherapy and Chemotherapy), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), and by Region (North America, Europe, Asia-Pacific, Middle East and Africa and Latin America) – Growth, Trends and Forecast, 2019-2028


Report Overview

The global Non-Small Cell Lung Cancer (NSCLC) therapeutics market size stood at around USD 18.14 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Non-small cell lung cancer accounts for 80%-85% of the total cases of lung cancer globally and this significant share of non-small cell lung cancer has driven the majority of key market leaders to focus on constant innovation of advanced therapeutics and increasing the efficacy of the existing therapeutics. This is also due to the status of lung cancer as one of the most commonly occurring cancers in the world and its contribution to a significant number of deaths worldwide.

Market Drivers

An increasing number of diagnoses of non-small cell lung cancer and the increasing awareness in the countries of the developed and developing markets are also contributing towards the non-small cell lung cancer therapeutics market growth. This, coupled with increasing investments by major players in research and development activities, and the inclusion of non-small cell cancer therapeutics in pipelines of major market players are also boosting the market growth globally.

Some of the other factors which are also contributing to the non-small cell lung cancer therapeutics market growth are the increase in the proportion of the smoking population and exposure to toxins such as asbestos. Greater adoption and increasing demand for targeted therapies, which is considered to be the foundation of precision medicine due to the increasing R&D initiatives and also due to its sophistication in targeting of cancerous cells, is one of the most prominent leading to factors that are responsible for the growth of the global NSCLC market.

Major NSCLC Market by Cancer Type

Based on cancer type, the global non-small cell lung cancer therapeutics market segments include adenocarcinoma, squamous cell carcinoma and large cell carcinoma.

1. Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview…..
A. Market Size
2. Market Growth Drivers and Restraints…………………………………..……………….
A. Market Drivers
I. Strong Pipeline and Increasing R&D
II. Rising Prevalence of NSCLC
B. Market Restraints
I. Pricing Pressure
3. Major NSCLC Market by Cancer Type…..…………………………………….………….
A. Adenocarcinoma
B. Squamous Cell Carcinoma
C. Large Cell Carcinoma
4. NSCLC Therapeutics Market Segmentation………………………..…………………….
A. By Therapy
I. Targeted Therapy
II. Immunotherapy
III. Chemotherapy
B. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
C. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle East and Africa Market Analysis
V. South America Market Analysis
5. NSCLC Therapeutics Major Market Share……………………………………………..….
A. Market Analysis, Insights and Forecast by Revenue
6. Competitive Landscape………………………………………………………….…………..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………….
A. F. Hoffman-La Roche Company overview, Product & Services, Strategies & Financials
B. Eli Lilly Company overview, Product & Services, Strategies & Financials
C. Celgene Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape….…………………………..………..
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Future Growth………………………………….………………………….
A. Key Industry Developments
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapy:

On the basis of therapy, the global non-small cell lung cancer therapeutics market is segmented into targeted therapy (which can be further sub-segmented into bevacizumab, dabrafenib/trametinib, erlotinib hydrochloride, osimertinib, and others), immunotherapy (which can be further sub-segmented durvalumab, nivolumab, atezolizumab, pembrolizumab) and chemotherapy. The targeted therapy segment dominated the global NSCLC therapeutics market in 2019. The segment accounted for 50.4% share of the market.

By Distribution Channel:

On the basis of distribution channel, the global non-small cell lung cancer therapeutics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

By Region:

Rising incidence of lung cancer and the increasing adoption of novel therapeutics will enable growth in Asia Pacific.

North America generated NSCLC therapeutics market revenue of US$ 7,190.3 Mn in 2019 and is anticipated to account for a dominant share in the global non-small cell lung cancer therapeutics market during the forecast period. The primary driving factor for the significant and strong growth of market is the fact that 80%-85% of the total lung cancer cases are comprised of NSCLC. With the increase in contributing factors of lung cancers such as the proportion of smokers in the general population and the exposure to toxins such as asbestos and elements of air pollution, is expected to give rise to the adoption of non-small cell lung cancer therapeutics. In developed countries, the adoption of advanced immunotherapies is growing with the other critical therapies of chemotherapy and targeted therapy.

Europe is estimated to be the second most dominant market after North America, driven by the adoption and R&D initiatives of advanced therapeutics. India and China in the Asia Pacific region are experiencing growth in the NSCLC therapeutics due to increased diagnosis of lung cancer. In terms of the dominance of therapies, chemotherapy is the most dominating therapy in these developing regions.

However, in countries like Japan, there is increased adoption and expenditure towards advanced immunotherapies and targeted therapies and Japan holds significant revenue shares in these advanced therapies. The adoption of advanced therapeutics is anticipated in the emerging regions of Latin America and the Middle East & Africa, due to the increasing prevalence of non-small cell lung cancer.

Top Major Players

Genentech, Inc. (F. Hoffmann-La Roche Ltd), Bristol Myers Squibb, Celgene and Merck Sharp & Dohme Corp. to be dominant players in the non-small cell lung cancer therapeutics market. Genentech, Inc. (F. Hoffmann-La Roche Ltd), emerged as the leading player with the highest non-small cell lung cancer therapeutics market share in 2018, as the company has a number of product offerings in the targeted therapy and immunotherapy segment, and these product offerings dominate a substantial portion of market share.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements